Oxidative pathways as a drug target for the treatment of autism

Kristi-Ann Villagonzalo1, Seetal Dodd, Olivia Dean

  • 1University of Melbourne, Department of Clinical and Biomedical Sciences, Victoria 3220, Australia. k.villagonzalo@pgrad.unimelb.edu.au

Abstract

Insights

Oxidative stress may contribute to autism's development. Research suggests antioxidant therapies could offer a new treatment approach for this complex neurodevelopmental disorder.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Developmental Disorders

Background:

  • Autism Spectrum Disorder (ASD) is a complex neurodevelopmental disorder with poorly understood causes.
  • Current treatments for ASD primarily address behavioral symptoms, not core features.
  • There is a need for novel therapeutic strategies targeting the underlying pathophysiology of autism.

Purpose of the Study:

  • To review current research on the role of oxidative stress in autism.
  • To explore potential therapeutic targets related to oxidative homeostasis in ASD.
  • To elucidate the underlying pathophysiology of autism.

Main Methods:

  • Comprehensive literature search up to June 2010.
  • Inclusion of studies from Medline, Pubmed, PsycINFO, CINAHL PLUS, and BIOSIS Previews.
  • Focus on genetic links, antioxidant levels, and oxidative stress markers in autism.

Main Results:

  • Evidence suggests altered oxidative homeostasis in individuals with autism.
  • Various oxidative biomarkers are significantly changed in autism.
  • This review synthesizes findings on oxidative stress markers and their relevance to ASD.

Conclusions:

  • Abnormalities in oxidative homeostasis may be implicated in the pathophysiology of autism.
  • Antioxidant interventions represent a promising therapeutic avenue for ASD.
  • Understanding oxidative stress mechanisms can guide future treatment development for autism.

Related Concept Videos

Phase I Oxidative Reactions: Overview01:19

Phase I Oxidative Reactions: Overview

Phase I biotransformation, or functionalization, is a crucial chemical process that converts drugs and other xenobiotics into more water-soluble forms, facilitating expulsion from the body. It involves oxidative, reductive, and hydrolytic reactions that add or unveil polar functional groups on lipophilic substrates. Key players in phase I reactions are the mixed-function oxidases. Situated in liver cell microsomes, these enzymes predominantly carry out drug metabolism. They require molecular...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems01:19

Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems

Phase I biotransformation reactions are integral to drug metabolism, predominantly involving oxidative, reductive, and hydrolytic transformations. Chief among these are oxidative reactions, which enhance the hydrophilicity of xenobiotics and introduce polar functional groups to facilitate their elimination from the body.
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
Autism Spectrum Disorder01:19

Autism Spectrum Disorder

Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
Phase I Reactions: Oxidation of Carbon-Heteroatom and Miscellaneous Systems01:15

Phase I Reactions: Oxidation of Carbon-Heteroatom and Miscellaneous Systems

Oxidative reactions are pivotal in metabolizing numerous compounds, including pharmaceutical drugs. These reactions often occur in carbon-heteroatom systems, such as carbon-nitrogen, carbon-sulfur, and carbon-oxygen.
In carbon-nitrogen systems, aliphatic and aromatic amines can undergo oxidative reactions. Secondary and tertiary amines, like those found in tricyclic antidepressants, can undergo N-dealkylation, a process that involves the oxidation of the alkyl group. In addition, oxidative...
Radical Autoxidation01:20

Radical Autoxidation

The oxidation of an organic compound in the presence of air or oxygen is called autoxidation. For example, cumene reacts with oxygen to form hydroperoxide. Autoxidation involves initiation, propagation, and termination steps. Many organic compounds are susceptible to autoxidation—especially ethers in the presence of oxygen, which form hydroperoxides. Even though this reaction is slow, old ether bottles contain small amounts of peroxide, which leads to laboratory explosions during ether...